{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:57:23Z","timestamp":1780563443036,"version":"3.54.1"},"reference-count":10,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.1080\/15563650.2022.2101469","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:46:23Z","timestamp":1660056383000},"page":"1094-1098","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England"],"prefix":"10.1080","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-3567","authenticated-orcid":false,"given":"A.","family":"King","sequence":"first","affiliation":[{"name":"Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Hill","sequence":"additional","affiliation":[{"name":"Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom"},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pucci","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-2520","authenticated-orcid":false,"given":"L.","family":"Keating","sequence":"additional","affiliation":[{"name":"Royal Berkshire NHS Foundation Trust, Reading, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"Epsom and St Helier NHS Trust, Epsom, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cantle","sequence":"additional","affiliation":[{"name":"King's College Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Sport and Specialised Analytical Services, Fordham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0581-6389","authenticated-orcid":false,"given":"S. H. L.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom"},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_143"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1110590"},{"key":"CIT0003","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report 2021: trends and developments, publications office of the European Union, Luxembourg; 2021. [cited 2022 March 11]. Available from: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13838\/TDAT21001ENN.pdf."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00644"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkab088"},{"key":"CIT0006","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Formal notification of N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl1H-indazole-3-carboxamide (ADB-BUTINACA) by Sweden as a new psychoactive substance under the terms of Regulation (EU) 2017\/2101. 2019. EU-EWS-RCS-FN-2019-0042."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3002"},{"key":"CIT0008","unstructured":"NPS Discovery. Synthetic cannabinoids in the Unbited States. Trend report Q4; 2021. [cited 2022 March 11]. Available from: https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2022\/02\/2021-Q4_Synthetic-Cannabinoids_Trend-Report.pdf."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1931692"},{"key":"CIT0010","unstructured":"Advisory Council on the Misuse of Drugs. Synthetic cannabinoid receptor agonists. 28 October 2020. London: Home Office; 2020. [cited 2022 March 11]. Available from: https:\/\/www.gov.uk\/government\/publications\/synthetic-cannabinoid-receptor-agonists."}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2022.2101469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T09:20:20Z","timestamp":1666862420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2022.2101469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"alternative-id":["10.1080\/15563650.2022.2101469"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2022.2101469","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}